Literature DB >> 6441950

Evaluation of the levels of free and total amitriptyline and metabolites in the plasma and brain of the rat after long-term administration of doses used in receptor studies.

P Baumann, J M Gaillard, M Jonzier-Perey, C Gerber, C Bouras.   

Abstract

This study was conducted in order to investigate the level of amitriptyline (AT) and its metabolites. Three separate experiments were carried out. In two of these experiments, rats were treated over 7 days with IP doses of AT (10 mg/kg in experiment A and 2 X 20 mg/kg in experiment C). The rats were sacrificed either 2 (experiment C) or 12 h (experiments A and C) after the last dose. In experiment B, rats were sacrificed 2 or 12 h after a single dose of 20 mg/kg AT. The results of these experiments showed the following: in experiment A only AT was measurable in the brain and in the plasma, in contrast to experiments B and C, where NT and the hydroxylated metabolites AT-OH and NT-OH reached significant levels in the plasma and in the brain. The concentrations of AT-OH, NT-OH, and NT (12-h values) that were found in the brain are probably not pharmacologically relevant. The 12-h plasma values of all compounds tested were, even with the highest dose, lower than those expected to be clinically effective in man. Our results suggest that AT, at higher doses, may induce its own metabolism. The free plasma levels of this drug and its metabolites are higher in man than in the rat. The possible implications of these results in the use of antidepressants in the treatment of depression are discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6441950     DOI: 10.1007/bf00431455

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  46 in total

1.  Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain.

Authors:  J Vetulani; F Sulser
Journal:  Nature       Date:  1975-10-09       Impact factor: 49.962

2.  Stimulation of drug metabolism in man by tricyclic antidepressants.

Authors:  K O'Malley; M Browning; I Stevenson; M J Turnbull
Journal:  Eur J Clin Pharmacol       Date:  1973-08       Impact factor: 2.953

3.  Chronic amitriptyline potentiates feeding induced by intrahypothalamic norepinephrine injections.

Authors:  J N Nobrega; D V Coscina
Journal:  Life Sci       Date:  1983-09-26       Impact factor: 5.037

4.  Guanosine triphosphate activation of brain adenylate cyclase: enhancement by long-term antidepressant treatment.

Authors:  D B Menkes; M M Rasenick; M A Wheeler; M W Bitensky
Journal:  Science       Date:  1983-01-07       Impact factor: 47.728

5.  Hydroxylated metabolites of tricyclic antidepressants: preclinical assessment of activity.

Authors:  W Z Potter; H M Calil; A A Manian; A P Zavadil; F K Goodwin
Journal:  Biol Psychiatry       Date:  1979-08       Impact factor: 13.382

6.  Modulation of dopamine-mediated behavioural responses by antidepressants: effects of single and repeated treatment.

Authors:  A Delini-Stula; A Vassout
Journal:  Eur J Pharmacol       Date:  1979-10-15       Impact factor: 4.432

7.  Pharmacokinetics of amitriptyline infused intravenously in man.

Authors:  A Jorgensen; V Hansen
Journal:  Eur J Clin Pharmacol       Date:  1976-09-30       Impact factor: 2.953

8.  Pharmacokinetics of chlorimipramine and its demethylated metabolite in blood and brain regions of rats treated acutely and chronically with chlorimipramine.

Authors:  E Friedman; T B Cooper
Journal:  J Pharmacol Exp Ther       Date:  1983-05       Impact factor: 4.030

9.  A liquid chromatographic method for quantitating amitriptyline in brain tissue.

Authors:  S H Preskorn; R K Glotzbach
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

10.  Alpha-2 adrenergic receptor sensitivity and the mechanism of action of antidepressant therapy. The effect of long-term amitriptyline treatment.

Authors:  D S Charney; G R Heninger; D E Sternberg
Journal:  Br J Psychiatry       Date:  1983-03       Impact factor: 9.319

View more
  7 in total

1.  Selectivity in the binding of psychotropic drugs to the variants of alpha-1 acid glycoprotein.

Authors:  C B Eap; C Cuendet; P Baumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-02       Impact factor: 3.000

Review 2.  Pharmacokinetic optimisation of tricyclic antidepressant therapy.

Authors:  M Furlanut; P Benetello; E Spina
Journal:  Clin Pharmacokinet       Date:  1993-04       Impact factor: 6.447

3.  Kinetic profiles of tianeptine and its MC5 metabolite in plasma, blood and brain after single and chronic intraperitoneal administration in the rat.

Authors:  W Couet; J Girault; F Latrille; C Salvadori; J B Fourtillan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Jan-Mar       Impact factor: 2.441

4.  Sertraline-induced desensitization of the serotonin 5HT-2 receptor transmembrane signaling system.

Authors:  E Sanders-Bush; M Breeding; K Knoth; M Tsutsumi
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  Plasma and brain pharmacokinetics of amitriptyline and its demethylated and hydroxylated metabolites after acute intraperitoneal injection in mice.

Authors:  F Coudore; J Fialip; A Eschalier; J Lavarenne
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Jan-Mar       Impact factor: 2.441

6.  Activity-based protein profiling identifies alternating activation of enzymes involved in the bifidobacterium shunt pathway or mucin degradation in the gut microbiome response to soluble dietary fiber.

Authors:  Bryan J Killinger; Christopher Whidbey; Natalie C Sadler; Adrian J DeLeon; Nathalie Munoz; Young-Mo Kim; Aaron T Wright
Journal:  NPJ Biofilms Microbiomes       Date:  2022-07-20       Impact factor: 8.462

7.  Antidepressant acts on astrocytes leading to an increase in the expression of neurotrophic/growth factors: differential regulation of FGF-2 by noradrenaline.

Authors:  Naoto Kajitani; Kazue Hisaoka-Nakashima; Norimitsu Morioka; Mami Okada-Tsuchioka; Masahiro Kaneko; Miho Kasai; Chiyo Shibasaki; Yoshihiro Nakata; Minoru Takebayashi
Journal:  PLoS One       Date:  2012-12-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.